Literature DB >> 11002765

Histopathological detection of owl's eye inclusions is still specific for cytomegalovirus in the era of human herpesviruses 6 and 7.

F M Mattes1, J E McLaughlin, V C Emery, D A Clark, P D Griffiths.   

Abstract

BACKGROUND: Cytomegalovirus (CMV) is the prototype member of the beta-herpesvirinae, which can cause multiple organ dysfunction in the immunocompromised host. Human herpesvirus 6 (HHV-6) and HHV-7 are newer members of the beta-herpesvirinae that can cause febrile illness in young children and are also possible pathogens in the immunocompromised patient. AIM: CMV is detected in histopathological sections by visualisation of owl's eye inclusion bodies. The aim of this study was to quantify the relation between CMV, HHV-6, and HHV-7 viral loads and the presence of owl's eye inclusions in histological sections.
METHODS: Histopathological examination of postmortem material and recording of owl's eye inclusion bodies were performed. CMV, HHV-6, and HHV-7 were detected by qualitative and quantitative polymerase chain reaction (PCR) from the same postmortem samples. Statistical analysis of the histopathological and PCR results was performed.
RESULTS: There was a significant association between the detection of owl's eye inclusion bodies and positive CMV PCR (p < 0.001); the median CMV viral load was significantly higher in samples that were positive for owl's eye inclusions (p < 0.001). No association was found between the presence of owl's eye inclusions and HHV-6 or HHV-7 positivity.
CONCLUSION: Histological detection of owl's eye inclusion bodies is an insensitive but highly specific method for detecting CMV organ involvement. Owl's eye inclusion bodies are not associated with HHV-6 or HHV-7 infection.

Entities:  

Mesh:

Year:  2000        PMID: 11002765      PMCID: PMC1762915          DOI: 10.1136/jcp.53.8.612

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?

Authors:  H K Osman; J S Peiris; C E Taylor; P Warwicker; R F Jarrett; C R Madeley
Journal:  J Med Virol       Date:  1996-04       Impact factor: 2.327

2.  Cytomegalovirus studies of autopsy tissue. II. Incidence of inclusion bodies and related pathologic data.

Authors:  F F Macasaet; K E Holley; T F Smith; T F Keys
Journal:  Am J Clin Pathol       Date:  1975-06       Impact factor: 2.493

Review 3.  Human herpesvirus 7.

Authors:  J B Black; P E Pellett
Journal:  Rev Med Virol       Date:  1999 Oct-Dec       Impact factor: 6.989

4.  HHV-6 and CMV pneumonitis in immunocompromised patients.

Authors:  K K Knox; D R Carrigan
Journal:  Lancet       Date:  1994-06-25       Impact factor: 79.321

5.  Isolation of a new herpesvirus from human CD4+ T cells.

Authors:  N Frenkel; E C Schirmer; L S Wyatt; G Katsafanas; E Roffman; R M Danovich; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 6.  Mechanism and application of genetic recombination in herpesviruses.

Authors:  K Umene
Journal:  Rev Med Virol       Date:  1999-07       Impact factor: 6.989

7.  Quantification of human cytomegalovirus DNA using the polymerase chain reaction.

Authors:  J C Fox; P D Griffiths; V C Emery
Journal:  J Gen Virol       Date:  1992-09       Impact factor: 3.891

8.  Human herpesvirus 7: another causal agent for roseola (exanthem subitum).

Authors:  K Tanaka; T Kondo; S Torigoe; S Okada; T Mukai; K Yamanishi
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

9.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

10.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

View more
  11 in total

1.  Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan.

Authors:  Masaaki Minami; Michio Ohta; Teruko Ohkura; Takafumi Ando; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Cytomegalovirus-induced pathology in human temporal bones with congenital and acquired infection.

Authors:  Vladimir Tsuprun; Nevra Keskin; Mark R Schleiss; Pat Schachern; Sebahattin Cureoglu
Journal:  Am J Otolaryngol       Date:  2019-08-02       Impact factor: 1.808

Review 3.  Investigation of CMV disease in immunocompromised patients.

Authors:  V C Emery
Journal:  J Clin Pathol       Date:  2001-02       Impact factor: 3.411

Review 4.  Resolution of ulcerative colitis.

Authors:  Markus F Neurath; Moritz Leppkes
Journal:  Semin Immunopathol       Date:  2019-07-05       Impact factor: 9.623

Review 5.  Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; Nikolaos Grigoriadis; Efthimia Petinaki; Georgios M Hadjigeorgiou
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

Review 6.  Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation.

Authors:  Raymund R Razonable; Randall T Hayden
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  Human cytomegalovirus infection and colorectal cancer risk: a meta-analysis.

Authors:  Bingjun Bai; Xingxing Wang; Engeng Chen; Hongbo Zhu
Journal:  Oncotarget       Date:  2016-11-22

Review 8.  Virus-Driven Carcinogenesis.

Authors:  Yuichiro Hatano; Takayasu Ideta; Akihiro Hirata; Kayoko Hatano; Hiroyuki Tomita; Hideshi Okada; Masahito Shimizu; Takuji Tanaka; Akira Hara
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

Review 9.  CMV in the gut: a critical review of CMV detection in the immunocompetent host with colitis.

Authors:  A L Goodman; C D Murray; J Watkins; P D Griffiths; D P Webster
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-06       Impact factor: 3.267

10.  Polymerase chain reaction for detection of mucosal cytomegalovirus infection in patients with acute ulcerative colitis.

Authors:  Gloria S Z Tun; Mohammad Raza; Melissa F Hale; Alan J Lobo
Journal:  Ann Gastroenterol       Date:  2018-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.